Providence Capital Advisors, LLC - ALTERITY THERAPEUTICS LTD ownership

ALTERITY THERAPEUTICS LTD's ticker is ATHE and the CUSIP is 02155X106. A total of 2 filers reported holding ALTERITY THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Providence Capital Advisors, LLC ownership history of ALTERITY THERAPEUTICS LTD
ValueSharesWeighting
Q4 2022$696
-30.4%
2,0000.0%0.00%
Q3 2022$1,0000.0%2,0000.0%0.00%
Q2 2022$1,000
-50.0%
2,0000.0%0.00%
Q1 2022$2,000
+100.0%
2,0000.0%0.00%
Q4 2021$1,000
-66.7%
2,0000.0%0.00%
-100.0%
Q3 2021$3,0002,0000.00%
Other shareholders
ALTERITY THERAPEUTICS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
OLD MISSION CAPITAL LLC 12,707$17,0000.00%
ADVANTAGE INVESTMENT MANAGEMENT, LLC 1,065$1,0000.00%
UBS Group AG 6,339$8,0000.00%
NEXT Financial Group, Inc 583$1,0000.00%
Advisor Group, Inc. 2,500$3,0000.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,128$16,0000.00%
MORGAN STANLEY 228,200$299,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,451$15,0000.00%
View complete list of ALTERITY THERAPEUTICS LTD shareholders